General Motors announced on January 22, 2026 that it will relocate production of the next‑generation Buick Envision from China to its Fairfax Assembly plant in Kansas City, Kansas, with the new line slated to begin in 2028.
The move is driven by the U.S. government’s 25% tariff on imported cars and a 10% tariff on auto parts that began in 2025, as well as the Trump administration’s broader push for domestic manufacturing. By shifting the Envision to the U.S., GM can avoid these tariffs, which are estimated to cost the company roughly $200 million per year in import duties.
GM has committed $5.5 billion in new investments over the past year to strengthen its U.S. manufacturing base, including $1.2 billion earmarked for the Fairfax plant to accommodate the Envision line and upgrade tooling and supply‑chain infrastructure.
The Fairfax plant will also begin producing the gas‑powered Chevrolet Equinox in 2027, while production of the Chevrolet Bolt is slated to end around the same time, freeing capacity for the Envision and allowing GM to streamline its product mix in the U.S. market.
Reshoring the Envision reduces supply‑chain risk, improves responsiveness to U.S. demand, and supports job creation in the region. For Buick, domestic production removes the tariff‑induced price premium, potentially boosting competitiveness against rivals such as the Honda CR‑V and Toyota RAV4. The decision also signals GM’s broader strategy to localize production of key models amid shifting trade policies.
"This decision further strengthens GM's domestic manufacturing footprint and supports U.S. jobs," said a GM spokesperson. The move aligns with the USMCA framework and reflects a broader industry trend of reshoring, positioning GM to capture growing demand for SUVs in the domestic market while mitigating geopolitical risks.
The announcement underscores GM’s commitment to a resilient, U.S.-focused supply chain and highlights the company’s proactive response to trade policy changes that could otherwise erode margins and competitiveness.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.